Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

VHT vs. JEHSX: which is better?

Bottom line

VHT vs JEHSX: the short answer

VHT (Vanguard Health Care Index Fund) and JEHSX (Health Sciences Trust) share a meaningful slice of their top holdings — about 79% by weight.

But VHT is far broader, holding 407 positions to 173 for JEHSX, so beyond the top names it adds exposure JEHSX doesn't have.

VHT is cheaper at 0.09% vs 1.04% — a difference of $95 a year per $10,000 invested.

Over five years, VHT returned +7.2% a year vs +4.2% for JEHSX (reporting dates differ).

Updated Nov 19, 2026

VHT vs JEHSX side by side

VHTJEHSX
TypeETFMutual fund
Fund familyVanguardJohn Hancock
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.09%1.04%
Annual cost per $10k$9$104
10-yr cost on $10k (prospectus)$115$1,282
Max front loadNone—
12b-1 fee0%0.05%
1-yr return+2.7%+19.5%
5-yr return (annualized)+7.2%+4.2%
10-yr return (annualized)+8.8%+8.7%
Best quarter+16.5%+23.6%
Worst quarter−13.1%−16.1%
Net assets (fund)$19.0B$251.3M
Number of holdings407173
Portfolio turnover4%68%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearVHTJEHSXDifference
2024+2.7%+1.8%+0.9%
2023+2.5%+4.3%−1.8%
2022−5.5%−13.1%+7.6%
2021+20.5%+11.2%+9.3%
2020+18.2%+27.2%−9.0%
2019+22.0%+28.7%−6.7%
2018+5.6%+0.7%+4.9%
2017+23.3%+27.5%−4.2%
2016−3.3%−10.6%+7.2%

Source: Fund prospectus bar charts

Holdings overlap

16 of VHT's top 25 holdings also appear in JEHSX's top 25.

Shared top holdings
HoldingVHTJEHSX
Eli Lilly & Co14.04%14.30%
Johnson & Johnson8.47%6.33%
AbbVie Inc6.09%5.28%
UnitedHealth Group Inc5.45%5.95%
Merck & Co Inc4.66%4.21%
Thermo Fisher Scientific Inc2.93%2.67%
Amgen Inc2.87%1.90%
Gilead Sciences Inc2.64%2.95%
Intuitive Surgical Inc2.38%1.98%
Abbott Laboratories2.35%2.00%
Bristol-Myers Squibb Co1.84%2.22%
Danaher Corp1.84%1.51%
CVS Health Corp1.83%0.98%
Vertex Pharmaceuticals Inc1.80%2.38%
Stryker Corp1.66%1.87%

Source: SEC Form N-PORT

VHT top 10

  1. Eli Lilly & Co — 14.04%
  2. Johnson & Johnson — 8.47%
  3. AbbVie Inc — 6.09%
  4. UnitedHealth Group Inc — 5.45%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 2.93%
  7. Amgen Inc — 2.87%
  8. Gilead Sciences Inc — 2.64%
  9. Intuitive Surgical Inc — 2.38%
  10. Pfizer Inc — 2.35%

JEHSX top 10

  1. Eli Lilly and Company — 14.30%
  2. Johnson and Johnson — 6.33%
  3. UnitedHealth Group Incorporated — 5.95%
  4. AbbVie Inc. — 5.28%
  5. Merck and Co. Inc. — 4.21%
  6. Gilead Sciences Inc. — 2.95%
  7. Thermo Fisher Scientific Inc. — 2.67%
  8. Vertex Pharmaceuticals Incorporated — 2.38%
  9. Bristol-Myers Squibb Company — 2.22%
  10. Abbott Laboratories — 2.00%

FAQ

What is the difference between VHT and JEHSX?
VHT (Vanguard Health Care Index Fund) and JEHSX (Health Sciences Trust) share a meaningful slice of their top holdings — about 79% by weight. But VHT is far broader, holding 407 positions to 173 for JEHSX, so beyond the top names it adds exposure JEHSX doesn't have.
Which is cheaper, VHT or JEHSX?
VHT has the lower expense ratio (0.09%).
Should I own both VHT and JEHSX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.